Articles related to Optometry

“Careers are long, but childhood is short. Our patients matter deeply and depend on us, but our families need us in ways no one else can replace.” – Dr. Luis G. León-Alvarado

According to Elizabeth Cifers, MBA, a practice management consultant specializing in retina practice: “The key is to focus on medical necessity for the information the test will provide, rather than ordering an OCTA routinely.”

“This acquisition immediately advances Biogen’s ongoing transformation… with two approved, best-in-class medicines that complement our existing portfolio.”
— Christopher Viehbacher, President and CEO, Biogen

Reproxalap is an investigational drug candidate for the treatment of dry eye disease.

“In discussions with ophthalmologists and optometrists, nearly all say they would choose SLT first if it were their own eye. However, when asked how often their patients receive SLT as initial therapy, most report rates around 10%.” – John Berdahl, MD, Vance Thompson Vision

TECNIS PureSee IOL is the first and only US FDA‑approved extended depth of focus (EDOF) IOL with no warning on loss of contrast sensitivity